Epicon Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Epicon Biotech General Information

Description

Operator of a joint venture incorporated to establish a provincial network of translational cellular therapies and bio-banking programs. The company engages in the business of developing aqueous humor derived exosome bio-bank to advance the diagnosis and therapeutics for ophthalmologic diseases as well as for processing, biobanking, and preparation of clinical-grade products for cellular therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ 07728
  • United States
Primary Industry
Biotechnology
Corporate Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ 07728
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epicon Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Epicon Biotech‘s full profile, request access.

Request a free trial

Epicon Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Epicon Biotech‘s full profile, request access.

Request a free trial

Epicon Biotech FAQs

  • When was Epicon Biotech founded?

    Epicon Biotech was founded in 2018.

  • Where is Epicon Biotech headquartered?

    Epicon Biotech is headquartered in Freehold, NJ.

  • What industry is Epicon Biotech in?

    Epicon Biotech’s primary industry is Biotechnology.

  • Is Epicon Biotech a private or public company?

    Epicon Biotech is a Private company.

  • What is Epicon Biotech’s current revenue?

    The current revenue for Epicon Biotech is .

  • Who are Epicon Biotech’s investors?

    Change Agents and Jiangsu Unicorn Biological Technology have invested in Epicon Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process